IBU-C TH 4 Tablet is a combination medication containing Aceclofenac 100 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and inflammation. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that exerts its therapeutic effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and fever. Thiocolchicoside is a muscle relaxant with anti-inflammatory and analgesic properties, acting as a selective GABA-A receptor agonist to relieve muscle spasms and stiffness. This combination is particularly effective in conditions such as acute musculoskeletal disorders, low back pain, osteoarthritis, and rheumatoid arthritis, where both inflammation and muscle spasm contribute to patient discomfort. IBU-C TH 4 Tablet provides symptomatic relief by addressing both inflammatory processes and muscle hyperactivity, improving mobility and quality of life. It is recommended to be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, peptic ulcer disease, and certain neurological conditions. Common adverse effects may include gastrointestinal discomfort, dizziness, and allergic reactions. Dosage and duration should be individualized based on clinical response and patient tolerance to minimize potential risks.